Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
A 2025 meta-analysis pooling three trials (878 participants) confirmed the pattern: significantly greater weight loss than placebo about ~14% of total body weight on average with no significant rise in overall adverse events [6] [7]
More Info: The landscape of modern metabolic health has been completely transformed by the introduction of GLP-1 receptor agonists
The levothyroxine dose was reduced to 137 g
Exercise helps maintain muscle mass, supports metabolic efficiency, and contributes to improved overall well-being
Semaglutide May Be Better If You: Want a medication with longer track record and more research Prefer having the option of pills instead of injections Have diabetes and need proven heart benefits Experience fewer side effects with single-hormone approach Semaglutide has proven cardiovascular benefits and can reduce the risk of heart attack and stroke in people with diabetes
In broad terms, Cigna commercial plans in 2026 cover Wegovy and Zepbound on Tier 3 with prior authorization
US$ 26.55
US$ 27.49
US$ 29.54
US$ 20.71
US$ 21.90
US$ 20.88
US$ 26.96
